BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3084423)

  • 1. Interstitial deletion of the short arm of chromosome 6 as a new cytogenetic marker of T-cell lymphoma.
    Maseki N; Kaneko Y; Sakurai M
    Jpn J Cancer Res; 1986 Apr; 77(4):334-7. PubMed ID: 3084423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom chromosome abnormalities in lymphoma.
    Bloomfield CD; Arthur DC; Frizzera G; Levine EG; Peterson BA; Gajl-Peczalska KJ
    Cancer Res; 1983 Jun; 43(6):2975-84. PubMed ID: 6850608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific chromosomal changes (aberrations)--supplementary marker of malignant degeneration in oncomorphologic studies].
    Anichkov NM; Mamaev NN; Mamaeva SE; Skripnik SV
    Arkh Patol; 1986; 48(6):87-91. PubMed ID: 3530204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neocentromere derived from a supernumerary marker deleted from the long arm of chromosome 6.
    Qin N; Bartley J; Wang JC; Warburton PE
    Cytogenet Genome Res; 2007; 119(1-2):154-7. PubMed ID: 18160796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial deletion of short arm of chromosome 11 limited to Wilms' tumor cells in a patient without aniridia.
    Kaneko Y; Egues MC; Rowley JD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4577-8. PubMed ID: 6272980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrations of chromosome 3. A marker of T-cell lymphomas?
    Gödde-Salz E
    J Genet Hum; 1983 Mar; 31(1):39-44. PubMed ID: 6604789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal natural killer/t-cell lymphoma, nasal type, in a patient with a constitutional 11q terminal deletion disorder.
    Gaitonde S; Attele A; Abutalib SA; Rondelli D; Lindgren V
    Acta Haematol; 2007; 118(1):42-6. PubMed ID: 17476097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between immunological phenotype and karyotype in malignant lymphoma.
    Levine EG; Arthur DC; Gajl-Peczalska KJ; LeBien TW; Peterson BA; Hurd DD; Bloomfield CD
    Cancer Res; 1986 Dec; 46(12 Pt 1):6481-8. PubMed ID: 3096564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
    Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonrandom karyotype changes in human retinoblastomas].
    Kuznetsova LE; Pogosiants EE; Muratova TT; Kozlovskaia GM
    Genetika; 1985 Feb; 21(2):321-6. PubMed ID: 3157614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal chromosome aberrations in a case of cutaneous T-cell lymphoma.
    Gamperl R
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):341-4. PubMed ID: 3484668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangements of the short arm of chromosome No. 6 in T-cell lymphomas.
    Mecucci C; Michaux JL; Tricot G; Louwagie A; van den Berghe H
    Leuk Res; 1985; 9(9):1139-48. PubMed ID: 3877852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic approaches to the clarification of pathogenesis in lymphoid malignancies: clinicopathologic characterization of 14q+ marker-positive non-T-cell malignancies.
    Fukuhara S; Nasu K; Kita K; Ueshima Y; Oguma S; Yamabe H; Nishigori M; Uchino H
    Jpn J Clin Oncol; 1983 Sep; 13(3):461-75. PubMed ID: 6580474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14q+ chromosome marker in a T-cell-rich B-cell lymphoma.
    La Starza R; Aventin A; Falzetti D; Stul M; Martelli MF; Falini B; Mecucci C
    J Pathol; 1996 Feb; 178(2):227-31. PubMed ID: 8683394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of a Hu-ets-1 allele in human leukemia cell lines ML-1, -2, and -3 with a chromosome change at 11q24.
    Ohyashiki K; Ohyashiki JH; Sandberg AA; Minowada J; Kinniburgh AJ
    Cancer Res; 1987 Jul; 47(14):3842-6. PubMed ID: 3109734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular cytogenetic approach on malignant lymphoma].
    Funato T
    Rinsho Byori; 1994 Jul; 42(7):682-8. PubMed ID: 8065032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic study of 4 patients diagnosed with splenic B-cell lymphoma with villous circulating cells].
    Solé F; Woessner S; Florensa L; Besses C; Palacín A; Martí M; Sans-Sabrafén J
    Sangre (Barc); 1993 Aug; 38(4):335-7. PubMed ID: 8235950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18).
    Horsman DE; Connors JM; Pantzar T; Gascoyne RD
    Genes Chromosomes Cancer; 2001 Apr; 30(4):375-82. PubMed ID: 11241790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.